Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region OSLO, Norway, Nov. 23, 2022 /PRNewswire/ -- Navamedic has signed an agreement with its partner InfoRLife SA (subsidiary of ACS…
Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region Oslo, 23 November 2022 - Navamedic has signed an agreement with its partner InfoRLife SA (subsidiary of ACS Dobfar S.p.A.)…
Navamedic ASA: Q3 2022 financial results OSLO, Norway, Nov. 1, 2022 /PRNewswire/ -- Oslo, 1 November 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company…
Navamedic ASA: Q3 2022 financial results Oslo, 1 November 2022 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to…
Navamedic ASA: Invitation to 2022 third quarter presentation Oslo, October 25, 2022 - Navamedic ASA (OSE: Nava) will be presenting its third quarter 2022 results on Tuesday November…
Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipation OSLO, Norway, Oct. 20, 2022 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) today announces the launch of ForlaxGO® across pharmacies in…
Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipation Oslo, 20 October 2022 – Navamedic ASA (OSE: NAVA) today announces the launch of ForlaxGO® across pharmacies in Norway, Sweden,…